These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 12629717)

  • 21. Drug therapy reviews: pathogenesis and clinical management of hyperuricemia and gout.
    Mangini RJ
    Am J Hosp Pharm; 1979 Apr; 36(4):497-504. PubMed ID: 433935
    [No Abstract]   [Full Text] [Related]  

  • 22. Pharmacokinetic and clinical studies of a new uricosuric agent - benzbromarone.
    Yu TF
    J Rheumatol; 1976 Sep; 3(3):305-12. PubMed ID: 978666
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effectiveness and tolerance of long-term uricosuric treatment].
    Berg H
    Z Gesamte Inn Med; 1990 Dec; 45(23):719-20. PubMed ID: 2102029
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Morin (3,5,7,2',4'-pentahydroxyflavone) exhibits potent inhibitory actions on urate transport by the human urate anion transporter (hURAT1) expressed in human embryonic kidney cells.
    Yu Z; Fong WP; Cheng CH
    Drug Metab Dispos; 2007 Jun; 35(6):981-6. PubMed ID: 17325024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of probenecid and benzbromarone on gluconeogenesis in isolated rat liver cells.
    Rodilla F; Sánchez-Beltrán MJ; Izquierdo R; Gómez-Ruiz MD; Cabo J
    Rev Esp Fisiol; 1989 Dec; 45(4):391-4. PubMed ID: 2631163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Benzbromarone: a double-edged sword that cuts the liver?
    Haring B; Kudlich T; Rauthe S; Melcher R; Geier A
    Eur J Gastroenterol Hepatol; 2013 Jan; 25(1):119-21. PubMed ID: 23196726
    [No Abstract]   [Full Text] [Related]  

  • 27. Involvement of uric acid transporter in increased renal clearance of the xanthine oxidase inhibitor oxypurinol induced by a uricosuric agent, benzbromarone.
    Iwanaga T; Kobayashi D; Hirayama M; Maeda T; Tamai I
    Drug Metab Dispos; 2005 Dec; 33(12):1791-5. PubMed ID: 16135657
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of hyperuricemia and gout].
    Gröbner W; Walter-Sack I
    Med Monatsschr Pharm; 2005 May; 28(5):159-64; quiz 165-6. PubMed ID: 15912988
    [No Abstract]   [Full Text] [Related]  

  • 29. Potentiation of anticoagulant effect of warfarin caused by enantioselective metabolic inhibition by the uricosuric agent benzbromarone.
    Takahashi H; Sato T; Shimoyama Y; Shioda N; Shimizu T; Kubo S; Tamura N; Tainaka H; Yasumori T; Echizen H
    Clin Pharmacol Ther; 1999 Dec; 66(6):569-81. PubMed ID: 10613612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A case of fulminant hepatitis, possibly caused by benzbromarone].
    Suzuki T; Suzuki T; Kimura M; Shinoda M; Fujita T; Miyake N; Yamamoto S; Tashiro K
    Nihon Shokakibyo Gakkai Zasshi; 2001 Apr; 98(4):421-5. PubMed ID: 11400273
    [No Abstract]   [Full Text] [Related]  

  • 31. The efficacy of treatment with allopurinol versus uricosuric drugs in gout.
    Weinberger A; Pinkhas J
    Panminerva Med; 1978; 20(3):155-6. PubMed ID: 757280
    [No Abstract]   [Full Text] [Related]  

  • 32. Antihyperuricemic lignans from the leaves of Phyllanthus niruri.
    Murugaiyah V; Chan KL
    Planta Med; 2006 Nov; 72(14):1262-7. PubMed ID: 16953466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Drug-induced hypouricemia: pathophysiology and application to the hyperuricemia with life style related disease].
    Hisatome I; Ogino K; Igawa O; Shigemasa C
    Nihon Rinsho; 2003 Jan; 61 Suppl 1():403-9. PubMed ID: 12629757
    [No Abstract]   [Full Text] [Related]  

  • 34. [The use of Allomaron in treating hyperuricemia].
    Balkarov IM
    Ter Arkh; 1994; 66(1):40-2. PubMed ID: 8146793
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of allopurinol on blood pressure and aortic compliance in hypertensive patients.
    Kostka-Jeziorny K; Uruski P; Tykarski A
    Blood Press; 2011 Apr; 20(2):104-10. PubMed ID: 21405957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Essential hypertension].
    Murakami H; Shimamoto K
    Nihon Rinsho; 2003 Jan; 61 Suppl 1():235-40. PubMed ID: 12629724
    [No Abstract]   [Full Text] [Related]  

  • 37. Uricosuric effect of irtemazole in hyperuricemic patients without and with renal insufficiency.
    Kamilli I; Gresser U; Pellkofer T; Löffler W; Zöllner N
    Z Rheumatol; 1989; 48(6):307-12. PubMed ID: 2623976
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [What is certain in gout therapy?].
    Gottesbüren H; Strohmeyer G
    Internist (Berl); 1971 Dec; 12(12):518-21. PubMed ID: 4945391
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of uricosuric and antiuricosuric agents on urate transport in human brush-border membrane vesicles.
    Roch-Ramel F; Guisan B; Diezi J
    J Pharmacol Exp Ther; 1997 Feb; 280(2):839-45. PubMed ID: 9023298
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Gout].
    Gröbner W; Zöllner N
    Z Rheumatol; 2004 Feb; 63(1):2-9. PubMed ID: 14991273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.